FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a pharmaceutical composition for oral administration, applicable for preventing and/or treating cancer, depression and a cognitive impairment, containing a substance described by formula (I), a pharmaceutically acceptable carrier and a dissolution agent.
EFFECT: producing new composition.
12 cl, 30 dwg, 46 tbl, 467 ex
Title | Year | Author | Number |
---|---|---|---|
TETRACYCLIC COMPOUNDS | 2010 |
|
RU2585622C2 |
TETRACYCLIC COMPOUNDS | 2010 |
|
RU2725140C2 |
NEW PHARMACEUTICAL COMPOSITION CONTAINING NONIONIC SURFACTANTS | 2015 |
|
RU2720680C2 |
CYCLIC CYANOENONE DERIVATIVES AS KEAP1 MODULATORS | 2021 |
|
RU2822828C1 |
SPIRO CONDENSED PYRROLIDINE DERIVATIVES AS INHIBITORS OF DEUBIQUITINATING ENZYMES (DUB) | 2017 |
|
RU2730552C2 |
DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE | 2014 |
|
RU2662832C2 |
TRICYCLIC COMPOUNDS OF BENZOPYRAN AS ANTIARRHYTHMIC AGENTS | 2005 |
|
RU2380370C2 |
IMIDES BASED PROTEOLYSIS MODULATORS AND RELATED METHODS OF USE | 2016 |
|
RU2704807C2 |
DRUG USED IN CARDIAC FAILURE | 1994 |
|
RU2128043C1 |
NOVEL COMPOUNDS OF SUBSTITUTED N-(3-FLUOROPROPYL)PYRROLIDINE, METHODS FOR PRODUCTION THEREOF AND THERAPEUTIC APPLICATION THEREOF | 2017 |
|
RU2742278C2 |
Authors
Dates
2016-01-20—Published
2011-08-19—Filed